Company: DARE
Filing Date: 2025-04-24
Form Type: ARS
Source: 0001401914-25-000018
Chunk: 260

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: ARS
Chunk 260
---
 Daré Bioscience, Inc., TriLogic Pharma, LLC and MilanaPharm LLC 10-K 001-36395 03/27/2020 10.10(d) 136

10.7(e) Amendment to License Agreement effective as of September 21, 2021 by and among Daré Bioscience, Inc., TriLogic Pharma, LLC and MilanaPharm LLC 10-Q 001-36395 11/10/2021 10.1 10.8+ License Agreement dated as of January 10, 2020 between Bayer HealthCare LLC and Daré Bioscience, Inc. 10-K 001-36395 03/27/2020 10.16 10.9+ Cooperative Research and Development Agreement entered into as of July 8, 2021 between Daré Bioscience, Inc. and the Eunice Kennedy Shriver National Institutes of Child Health and Human Development Institute 10-Q 001-36395 11/10/2021 10.2 10.10+ License Agreement dated as of August 12, 2023 between Douglas Pharmaceuticals Limited and Daré Bioscience, Inc. X 10.11+ Grant Agreement between Daré Bioscience, Inc. and the Bill & Melinda Gates Foundation effective as of June 30, 2021, as amended to date X 10.12+ Grant Agreement between Daré Bioscience, Inc. and the Bill & Melinda Gates Foundation effective as of November 11, 2024, as amended to date X 10.13+ Subaward Agreement between the Consortium Management Firm, National Collegiate Inventors and Innovators Alliance, Inc. d/b/a/ VentureWell and Daré Bioscience, Inc., effective as of October 12, 2024 X 10.14 Royalty Interest Financing Agreement entered into as of December 21, 2023 between Dare Bioscience, Inc. and United in Endeavor, LLC 10-K 001-36395 03/28/2024 10.12 10.15 Purchase Agreement, dated October 21, 2024, by and between Daré Bioscience, Inc. and Lincoln Park Capital Fund, LLC 8-K 001-36395 10/21/2024 10.1 10.16 Registration Rights Agreement, dated October 21, 2024, by and between Daré Bios